Can biotechnology save the developing world?
Learn how the industry hopes to ease the burden of disease, secure the food supply, and provide more affordable energy.

Connect and develop with Procter & Gamble Pharmaceuticals, the sponsor of the debut issue of the magazine.

FOLLOWING THE BASICS ENHANCES FORECASTING

By Ken Wilan

In 1997, Centocor had a promising drug in Phase II trials and a pharmaceutical company, Schering-Plough, interested in a deal to market it internationally. The only problem was that the drug, a biologic aimed at Crohn's disease and rheumatoid arthritis, would be first in the space and thus no historical data existed about the size of the potential market. That number, of course, was key to the company's future.

"The historical research wasn't very useful, so we needed new information," says James Schoeneck, then general manager of the immunology business unit at Centocor and a key negotiator in the deal. Enter forecasting. Centocor did its information gathering and modeling, and entered negotiations projecting an approximate $1 billion international market by 2007. Schering-Plough, however, predicted annual sales of around $300 million.

While the two companies were far apart in their forecasts, Schoeneck's team was confident that it had done a thorough job getting at the assumptions, and it stuck with its prediction. Rather than negotiating based on a compromised number, or walking away from the deal, Centocor structured the deal to reflect its team's confidence. The company took a lower percentage on sales up to the number Schering-Plough was predicting, but would then get a percentage bump above it. "We knew if we were right, we would have a lot of money coming in," says Schoeneck. "Yes, we would lose something" if Centorcor's number was wrong, he says, but Schoneck and his colleagues focused on the upside.

The company's confidence was eventually validated: In 1999, Johnson & Johnson acquired Centocor, and Remicade, the monoclonal antibody that had been the subject of the earlier negotiations, reached annual sales of just under $942 million outside the United States in 2005. More than using complex models to get an accurate forecast, Centocor depended on following some forecasting fundamentals.


 
Web Developer - Jason Barry NJ Wedding Photography PA Wedding Photography